MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from private
placement financing, net...
$75,116K
Proceeds from exercise of
options and employee...
$91K
Net cash provided by
financing activities
$75,207K
Net decrease in
cash, cash...
-$13,148K
Canceled cashflow
$75,207K
Sales/maturities of marketable
securities
$42,000K
Stock-based compensation
expense
$4,807K
Noncash operating lease
expense
$1,187K
Depreciation and
amortization expense
$273K
Net cash (used in)
provided by investing...
-$49,854K
Canceled cashflow
$42,000K
Net cash used in
operating activities
-$38,334K
Effect of exchange
rates on cash, cash...
-$167K
Canceled cashflow
$6,267K
Purchase of marketable
securities
$91,854K
Unrealized gain on equity
investments
$21,052K
Net loss
-$17,414K
Prepaid expenses and
other current assets
$1,802K
Change in lease
liability
-$1,336K
Accounts payable
-$1,234K
Accrued expenses
-$1,068K
Change in accrued
interest and accretion of...
-$695K
Back
Back
Cash Flow
source: myfinsight.com
Ovid Therapeutics Inc. (OVID)
Ovid Therapeutics Inc. (OVID)